Skip Navigation

A Randomized Phase II Study of Trastuzumab and Pertuzumab TP Compared to Cetuximab and Irinotecan CETIRI in Advanced/Metastatic Colorectal Cancer MCRC with HER-2 Amplification

Brief Summary

Type:
Colorectal

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03365882

Study #:
STUDY00141842

Start Date:
Mar 22, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03365882

View Complete Trial Details & Eligibility at ClinicalTrials.gov